1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Sepax Technologies, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2002

Location

Suzhou Jiangsu China

Primary Industry

Biotechnology

About

Established in 2002, based in Suzhou, China and headquartered in Delaware, US, Sepax Technologies, Inc. operates as a biotechnology company which focuses on chromatographic separation science and liquid chromatography packing. The company is mainly involved in the field of analytical chromatography, industrial purification and medical diagnosis. The company self developed analytical chromatography products include size exclusion chromatography column, ion exchange chromatography column, affinity chromatography column, hydrophobic chromatography column, hydrophobic reverse phase chromatography column, polymer reverse phase chromatography column, silica gel reverse phase chromatography column, other silica gel chromatography column, pharmacopoeia special column, solid phase extraction cartridges, chromatographic accessories and chromatographic column test standards. Besides, the industrial purification products include affinity fillers, composite chromatography fillers, ion exchange fillers, size exclusion fillers, hydrophobic fillers, silica matrix fillers, polymer reversed phase fillers, other silica matrix fillers and FPLC (Fast protein liquid chromatography) chromatography column tubes. The company plans to use the series D funding for accelerate the improvement of the research, development, production and operation capabilities of the analytical chromatography and industrial purification business segments.
Current Investors
Huatai Zijin Investment, Comway Capital, Fosun International

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.sepax-tech.com.cn
Company Stage
Series D
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.